Current and Future Perspectives in Psychiatric Drug Discovery.
On March 12, 2009, the Society for Medicines Research held a 1-day meeting entitled Current and Future Perspectives in Psychiatric Drug Discovery at GlaxoSmithKline, Harlow, U.K. The meeting, organized by Wendy Alderton, Eric Karran and Simon Ward, brought together experts from industry and academia to review the current challenges in the treatment of depression, schizophrenia and addiction. Recent advances in the development of novel agents for the treatment of these diseases were also presented.
Alderton
Wendy
W
Zebrafish Business Unit, Summit plc, Oxford, UK. secretariat@smr.org.uk
Karran
Eric
E
Ward
Simon
S
D000818:Animals; D003071:Cognition / Q000187:drug effects; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D015195:Drug Design; D055808:Drug Discovery; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D016540:Smoking Cessation / Q000379:methods; D019966:Substance-Related Disorders / Q000188:drug therapy*